Tenet Remedies Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.10 M
- Company Age 8 Year, 2 Months
- Last Filing with ROC 31 Mar 2020
- Revenue Growth -55.15%
- Profit Growth -109.02%
- Ebitda -55.97%
- Net Worth -4.15%
- Total Assets -68.64%
About Tenet Remedies
Tenet Remedies Private Limited (TRPL) is a Private Limited Indian Non-Government Company incorporated in India on 29 November 2016 (Eight years and two months 14 days old ). Its registered office is in Patna, Bihar, India.
The Company is engaged in the Business Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2020. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Raj Ray, Anupama Verma, Nisha Singh, and Two other members serve as directors at the Company.
Company Details
-
Location
Patna, Bihar, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U74999BR2016PTC032964
-
Company No.
032964
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
29 Nov 2016
-
Date of AGM
30 Dec 2020
-
Date of Balance Sheet
31 Mar 2020
-
Listing Status
Unlisted
-
ROC Code
Roc Patna
Industry
Who are the key members and board of directors at Tenet Remedies?
Board Members (5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Raj Ray
|
Director | 29-Nov-2016 | Current |
|
Anupama Verma
|
Additional Director | 17-Nov-2017 | Current |
|
Nisha Singh
|
Additional Director | 17-Nov-2017 | Current |
|
Rahul Sinha
|
Additional Director | 17-Nov-2017 | Current |
|
Rajeev Sinha
|
Director | 29-Nov-2016 | Current |
Financial Performance of Tenet Remedies.
Tenet Remedies Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 55.15% decrease. The company also saw a substantial fall in profitability, with a 109.02% decrease in profit. The company's net worth dipped by a decrease of 4.15%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Tenet Remedies?
Unlock access to Tenet Remedies's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Tozox Pharmaceuticals Private LimitedRahul Sinha is a mutual person
-
Uditsky Infra Private Limited
Rajeev Sinha is a mutual person
-
Macauly Organic Private Limited
Rajeev Sinha is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Tenet Remedies?
Unlock and access historical data on people associated with Tenet Remedies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Tenet Remedies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Tenet Remedies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
